Menu
Back to User profile » Ms Pakapan Woottiluk
Papers published by Ms Pakapan Woottiluk:
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
Maneeton B, Maneeton N, Likhitsathian S, Woottiluk P, Wiriyacosol P, Boonyanaruthee V, Srisurapanont M
Neuropsychiatric Disease and Treatment 2018, 14:1953-1961
Published Date: 2 August 2018
Risperidone for children and adolescents with autism spectrum disorder: a systematic review
Maneeton N, Maneeton B, Putthisri S, Woottiluk P, Narkpongphun A, Srisurapanont M
Neuropsychiatric Disease and Treatment 2018, 14:1811-1820
Published Date: 11 July 2018
Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
Maneeton B, Putthisri S, Maneeton N, Woottiluk P, Suttajit S, Charnsil C, Srisurapanont M
Neuropsychiatric Disease and Treatment 2017, 13:1023-1032
Published Date: 4 April 2017
Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials
Maneeton N, Maneeton B, Woottiluk P, Likhitsathian S, Suttajit S, Boonyanaruthee V, Srisurapanont M
Drug Design, Development and Therapy 2016, 10:259-276
Published Date: 12 January 2016
Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
Maneeton N, Maneeton B, Woottiluk P, Suttajit S, Likhitsathian S, Charnsil C, Srisurapanont M
Neuropsychiatric Disease and Treatment 2015, 11:2943-2952
Published Date: 25 November 2015
Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P
Drug Design, Development and Therapy 2015, 9:1927-1936
Published Date: 1 April 2015